Filed: 8/15/2025ACC: 0001802630-25-000008
📋 What this filing means
SOLEUS CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 95 equity positions with a total reported market value of $1.51B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
95
Positions
$1.51B
Total AUM (reported)
141.13M
Total Shares
Allocation by class
COM$992.59M65.7%
COM NEW$135.33M9.0%
ORD SHS$126.17M8.4%
S&P BIOTECH$62.20M4.1%
SP ADR REP B NVT$52.04M3.4%
SPONSORED ADR$50.37M3.3%
COM PAR $0.01$50.08M3.3%
Portfolio Concentration
Top 3$330.53M21.9%
4–10$375.00M24.8%
11–25$414.92M27.5%
Rest$389.66M25.8%
Top 3 weight
21.9%
Top 10 weight
46.7%
Voting Authority Distribution
Total shares with voting rights: 141.13M
Sole
Full voting authority
141.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole95
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings95
Rows:
KRYSTAL BIOTECH INC
SOLEShares922.96K
TypeSH
Market value$126.87M
8.40%
Sole
922.96K
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares6.90M
TypeSH
Market value$122.90M
8.14%
Sole
6.90M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares2.24M
TypeSH
Market value$80.76M
5.35%
Sole
2.24M
Shared
0.00
None
0.00
SPDR SERIES TRUST
SOLEShares750K
TypeSH
Market value$62.20M
4.12%
Sole
750K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares209.79K
TypeSH
Market value$60.28M
3.99%
Sole
209.79K
Shared
0.00
None
0.00
BETA BIONICS INC
SOLEShares3.82M
TypeSH
Market value$55.62M
3.68%
Sole
3.82M
Shared
0.00
None
0.00
GRIFOLS S A
SOLEShares5.76M
TypeSH
Market value$52.04M
3.45%
Sole
5.76M
Shared
0.00
None
0.00
STAAR SURGICAL CO
SOLEShares2.98M
TypeSH
Market value$50.08M
3.32%
Sole
2.98M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares902.30K
TypeSH
Market value$49.60M
3.28%
Sole
902.30K
Shared
0.00
None
0.00
ORGANOGENESIS HLDGS INC
SOLEShares12.34M
TypeSH
Market value$45.18M
2.99%
Sole
12.34M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares966.74K
TypeSH
Market value$40.65M
2.69%
Sole
966.74K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares3.01M
TypeSH
Market value$40.21M
2.66%
Sole
3.01M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares106.75K
TypeSH
Market value$34.81M
2.31%
Sole
106.75K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares8.17M
TypeSH
Market value$30.46M
2.02%
Sole
8.17M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares2.19M
TypeSH
Market value$29.93M
1.98%
Sole
2.19M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares2.42M
TypeSH
Market value$27.60M
1.83%
Sole
2.42M
Shared
0.00
None
0.00
ELEVANCE HEALTH INC
SOLEShares70K
TypeSH
Market value$27.23M
1.80%
Sole
70K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares86.25K
TypeSH
Market value$26.91M
1.78%
Sole
86.25K
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.31M
TypeSH
Market value$25.77M
1.71%
Sole
2.31M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares42.88K
TypeSH
Market value$23.63M
1.57%
Sole
42.88K
Shared
0.00
None
0.00
SURMODICS INC
SOLEShares789.06K
TypeSH
Market value$23.44M
1.55%
Sole
789.06K
Shared
0.00
None
0.00
GERON CORP
SOLEShares16.14M
TypeSH
Market value$22.76M
1.51%
Sole
16.14M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares462.81K
TypeSH
Market value$22.54M
1.49%
Sole
462.81K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares2.12M
TypeSH
Market value$19.52M
1.29%
Sole
2.12M
Shared
0.00
None
0.00
HUMANA INC
SOLEShares79.60K
TypeSH
Market value$19.46M
1.29%
Sole
79.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KRYSTAL BIOTECH INCSOLE | COM | 922.96K | SH | $126.87M 8.40% | 922.96K | 0.00 | 0.00 |
NOVOCURE LTDSOLE | ORD SHS | 6.90M | SH | $122.90M 8.14% | 6.90M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 2.24M | SH | $80.76M 5.35% | 2.24M | 0.00 | 0.00 |
SPDR SERIES TRUSTSOLE | S&P BIOTECH | 750K | SH | $62.20M 4.12% | 750K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 209.79K | SH | $60.28M 3.99% | 209.79K | 0.00 | 0.00 |
BETA BIONICS INCSOLE | COM | 3.82M | SH | $55.62M 3.68% | 3.82M | 0.00 | 0.00 |
GRIFOLS S ASOLE | SP ADR REP B NVT | 5.76M | SH | $52.04M 3.45% | 5.76M | 0.00 | 0.00 |
STAAR SURGICAL COSOLE | COM PAR $0.01 | 2.98M | SH | $50.08M 3.32% | 2.98M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 902.30K | SH | $49.60M 3.28% | 902.30K | 0.00 | 0.00 |
ORGANOGENESIS HLDGS INCSOLE | COM | 12.34M | SH | $45.18M 2.99% | 12.34M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 966.74K | SH | $40.65M 2.69% | 966.74K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 3.01M | SH | $40.21M 2.66% | 3.01M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 106.75K | SH | $34.81M 2.31% | 106.75K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 8.17M | SH | $30.46M 2.02% | 8.17M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 2.19M | SH | $29.93M 1.98% | 2.19M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 2.42M | SH | $27.60M 1.83% | 2.42M | 0.00 | 0.00 |
ELEVANCE HEALTH INCSOLE | COM | 70K | SH | $27.23M 1.80% | 70K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 86.25K | SH | $26.91M 1.78% | 86.25K | 0.00 | 0.00 |
NEUROPACE INCSOLE | COM | 2.31M | SH | $25.77M 1.71% | 2.31M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 42.88K | SH | $23.63M 1.57% | 42.88K | 0.00 | 0.00 |
SURMODICS INCSOLE | COM | 789.06K | SH | $23.44M 1.55% | 789.06K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 16.14M | SH | $22.76M 1.51% | 16.14M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 462.81K | SH | $22.54M 1.49% | 462.81K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 2.12M | SH | $19.52M 1.29% | 2.12M | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 79.60K | SH | $19.46M 1.29% | 79.60K | 0.00 | 0.00 |
Page 1 of 4